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Abstract
Objective—To fine map previously identified quantitative trait loci (QTL) affecting
atherosclerosis in mice using association analysis.
Methods and Results—We recently showed that high-resolution association analysis using
common inbred strains of mice is feasible if corrected for population structure. To utilize this
approach for atherosclerosis, which requires a sensitizing mutation, we bred human apoB100
transgenic mice with 22 different inbred strains to produce F1 heterozygotes. Mice carrying the
dominant transgene were tested for association with high-density SNP maps. Here we focus on
high-resolution mapping of the previously described Ath30 locus on Chr 1. As compared to the
previous linkage analysis, association improved the resolution of the Ath30 locus by more than an
order of magnitude. Using expression quantitative trait locus analysis, we identified one of the
genes in the region, Des, as a strong candidate.
Conclusions—Our high-resolution mapping approach accurately identifies and fine maps
known atherosclerosis QTL. These results suggest that high-resolution genome-wide association
analysis for atherosclerosis is feasible in mice.
INTRODUCTION
Genome-wide association (GWA) studies of large numbers of patients and controls have
identified over 30 loci involved in atherosclerosis1. Many of those loci appear to involve
genes not previously associated with atherosclerosis, providing an opportunity for the
discovery of new pathways involved in the disease. While clearly exciting, such human
studies have some significant limitations. Notably, the loci explain a small fraction of the
heritability of the disease, and the causal genes/mutations at most of the loci are unknown2.
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Also, examination of epistatic effects and gene-by-environment interactions in human
populations is complicated by low power and the inability to accurately quantify
environmental exposures3. Finally, intermediate phenotypes such as transcript levels are
difficult to obtain.
Over 30 atherosclerotic quantitative trait loci (QTL) in mice have been mapped by linkage
in crosses between various inbred strains indicating that there exists a wealth of relevant
genetic variation in laboratory mice4. However, the poor resolution of these QTLs, generally
encompassing hundreds of genes, has made it difficult to identify the underlying causal
gene(s). Our group, along with others, has been developing association-based approaches to
specifically address the poor resolution of linkage studies5, 6. We have shown that
association mapping in classic inbred strains of mice is feasible and has good power
provided that the data are corrected for population structure5, 7, 8.
One difficulty in applying an association strategy to atherosclerosis in mice is that a
sensitizing mutation resulting in hyperlipidemia is required to allow rapid development of
substantial lesions. The most widely used models are Apoe−/− 9, 10 and Ldlr−/− mice11. Both
of these act in a recessive manner with respect to lesion development, and breeding either of
these mutations to a homozygous state in numerous strains for an association study is not
practical. To circumvent this problem, we employed a dominant hyperlipidemia-inducing
mutation, the human apolipoprotein B-100 transgenic , C57BL/6-tg(APOB)12. Our approach
uses F1 mice generated by breeding C57BL/6-tg(APOB) mice with permanent inbred strains
followed by association mapping.
Using this strategy, we have now analyzed a limited number of inbred strains for association
using an efficient mixed model algorithm (EMMA) that corrects for population structure.
Although the data are not yet sufficiently powered for genome-wide association analysis, we
have used them to demonstrate both the concordance with loci identified in previous linkage
studies and the improved mapping resolution at one previously mapped locus, Ath30.
Examination of mRNA levels in the aorta narrowed our list of candidate genes. We show
that one of these candidates, Des, is differentially regulated during atherogenesis.
RESULTS
A strategy for performing association mapping on a sensitizing genetic background
Several groups have identified QTL for atherosclerosis using crosses between inbred
mice8, 13–17. Identifying candidate genes for further testing using traditional congenic
approaches is time consuming, and sometimes the loci are complex, containing several
genes affecting the phenotype 18. One approach to fine mapping QTL is to use association
analysis with different inbred and recombinant inbred strains. We bred hemizygous C57BL/
6-tg(APOB) mice to 22 different inbred strains to generate F1 heterozygous mice carrying
the transgene. Beginning at 9 weeks of age, these mice were fed an atherogenic diet with
cholic acid. Following 16 weeks of the diet, we quantitated plasma lipoproteins and
atherosclerosis. Mean atherosclerotic lesion sizes in females ranged between 0 um2 for
NZW/LacJ and 73,291 um2 in BXH20/KccJ mice (Fig. 1A). The extent of lesion
development was markedly lower in males, ranging from 148 um2 for CBA/J to 19,831 um2
in C57BL/6J mice (Fig. 1B). Representative lesions are shown in Suppl. Fig. I and the
numbers of mice per strain are summarized in Suppl. Table I. There was strong concordance
of atherosclerosis susceptibility among the strains by gender (r=0.87, p=1.8×10−7). The use
of the tg(APOB) as a sensitizing mutation to atherosclerosis provided a substantial increase
in the robust nature of lesion formation as compared to dietary manipulation alone. For
example, compared to publically available data at the mouse phenome database (http://
phenome.jax.org/), we observed over a 10-fold increase in lesion size as compared to mice
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on diet alone. Lesion size in the current study correlated well with previous studies including
Paigen 1 (r=0.80, p<0.003) and our survey of BXH RI mice8 (r=0.86, p=0.009) (Suppl. Fig.
II). These correlations demonstrate that the F1 approach effectively recapitulates strain
effects found in previous studies.
Circulating high-density lipoprotein levels (HDL) varied between strains (Fig. 1C and 1D)
and were negatively correlated with atherosclerotic burden in both males (r=−0.40, p<0.001)
and females (r=−0.48, p<0.001) (Fig. 1E and 1F). There was also a significant positive
correlation between circulating total cholesterol levels and atherosclerosis in males (r=0.23,
p=0.005) and females (r=0.35, p<2×10−5) (data not shown).
Association analysis of atherosclerosis and atherosclerosis risk factors
We next performed association analysis for atherosclerosis using the efficient mixed model
association (EMMA) algorithm to correct for underlying population structure19, thereby
reducing the number of false positive association signals (Suppl. Fig. III). The analysis was
performed on females (Fig. 2A), males (Fig. 2B) and on both genders with sex as a covariate
(Fig. 2C) using more than 75,000 single nucleotide polymorphisms (SNPs). Using a 5%
false discovery rate (FDR), several loci exhibited significant association (Fig. 2 and Table
1). We then compared our association results with previously identified QTL for
atherosclerosis. We complied a list of genome-wide significant atherosclerosis QTL by
querying the mouse genome informatics website (http://www.informatics.jax.org). We
defined a 95% confidence interval for a QTL to be 20 Mb and found 30 independent QTL
(not within 20 Mb of each other). We compared these historical loci with the results of our
current study (Table 1). For each analysis (males, females and combined genders), we
observed significant overlap of our results with the historical QTL based on linkage20–26.
For example, for females 4 out of 5 loci map within 10 Mb of a previous QTL (p<0.01 using
binomial probability). For males, the results were 4 out of 8 loci (p=0.07), and for combined
genders, 4 out of 5 loci (p=0.036). Overall, these data suggest that association analysis in
mice offers robust mapping potential for atherosclerosis.
We repeated our association analysis for circulating levels of both high-density lipoprotein
(HDL) and total cholesterol (Suppl. Figs. IV, V). We used EMMA corrected p-values,
identified loci exceeding a 5% FDR and compared these to published loci27 and the mouse
genome informatics website, http://www.informatics.jax.org. Compared to historical results,
we observed that 12 out of the 13 associations in our results mapped within 10 Mb, the peak
marker of a previously reported lipid QTL (Suppl.Table II). As in the case of
atherosclerosis, this represents a significant enrichment using a binomial test (p<0.0007),
and some of the lipoprotein loci overlapped with the atherosclerosis loci. For example, the
locus responsible for lesion size on Chromosome (Chr) 4 also perturbed HDL, suggesting a
possible casual relationship. This locus has been previously mapped for HDL levels in 4
independent crosses27 and contains two postulated candidate genes, Abca1 and Cyp7a1.
Replication in an independent dataset
We were particularly interested in two loci, on Chr 1 at 76 Mb and Chr 4 at 59 Mb, as we
have previously mapped these loci in F2 crosses between C3H/HeJ and C57BL/J mice with
a Apoe−/− mutation (BXH.Apoe−/−) 25, 28. We next tested if these two loci replicated in an
independent dataset. Paigen and colleagues have performed studies of atherosclerosis on
multiple inbred strains of mice using a diet that includes cholic acid and results in much
smaller lesions than those in genetically modified mice, including the present study29–31.
Nevertheless, since the results of Paigen 1, available in the Mouse Phenome Database of
The Jackson Laboratories (http://phenome.jax.org/), were consistent with our results using
the tg(APOB) mice, we performed association analysis. After removal of the wild-derived
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strains (since these confound association due to their large genetic distance from laboratory
strains), the Paigen 1 subset contains 31 strains. As shown by the association plot (Figure 3),
there is significant evidence of association at both the Ath30 (p< 1.3×10−2) and Ath8 (p< 3.8
× 10−4) loci, consistent with our results.
Fine mapping of previously identified Ath30 locus
We chose to focus on the association peak at around 75 Mb on Chr 1 since it was the
strongest peak in our association data in females, males, and the combined dataset (Fig. 2),
and it corresponded well to the position of Ath30 that we previously identified in the
BXH.Apoe−/− F2 cross 25. We were also able to confirm this locus using the Paigen 1 study.
We defined the resolution of our association panel using linkage disequilibrium (LD) by
calculating the correlation among SNPs used in this study. Historical recombination events
determine the amount of correlation among markers and thus highly correlated SNPs form
blocks along chromosomes, as in human populations. The boundaries of these blocks
determine the genetic resolution, defining the candidate genes underlying an association. We
compared the LD for Chr 1 in the current study with that of the BXH.Apoe−/−F2 (Suppl.
Figs. VI). As can be seen, association results in greatly improved resolution by more than an
order of magnitude. For example, in the current study, the average r2 over a 100 Mb sliding
window was 0.6 for markers 100kb apart and 0.4 for markers 1 Mb apart (Suppl. Figs. VI).
We observed three SNPs (rs31896983, rs32179781 and rs30136637) in the Ath30 region
that were most strongly associated with atherosclerosis in males and females (Fig. 4A). The
SNPs were located in the region 74.8 to 76.5 Mb, in strong LD with one another (Fig. 4C),
and were not associated with lipid traits. The region contained 31 protein coding genes and 1
miRNA gene. The physical locations of these are shown in Fig. 4B.
We examined which of these genes have a structural variant using re-sequencing data from
the recently released mouse genomes database (http://www.sanger.ac.uk/resources/mouse/
genomes/). Analysis of SNPs with coding changes identified 13 genes with altered structure
(Suppl. Table III) but only one of these, Speg, also known as aortic preferentially expressed
protein 1 (Apeg1), has been associated with atherosclerosis in the literature32.
The Ath30 locus was not associated with lipid levels in this study and the original report25
and thus we hypothesized that the effects of the locus might be vessel wall specific. To
address this we analyzed the aortic gene expression from 93 strains of mice (Suppl. Table
IV). Because analysis of aortas from hyperlipidemic mice would be confounded by
differences in atherosclerotic lesion composition, we chose to quantitate mRNA from non-
hyperlipidemic mice from the HMDP. In particular, two of these positional candidates,
desmin (Des) and galactosidase, beta 1-like (Glb1l), were genetically regulated by this locus
with highly significant local eQTL, 8.4×10−7 for Glb1l and 1.2×10−5 for Des (Fig. 5). P-
values for all 31 genes and physical positions of SNPs regulating Glb1l and Des expression
are listed in Suppl. Table V.
To further explore the possible relevance of the genes to atherosclerosis, we examined their
expression in endothelial cells isolated from aortas of C57BL/6J Apoe−/− and wild type
C57BL/6J (wt) females at 4 and 24 weeks of age. We found that Des mRNA levels were
significantly upregulated in endothelial cells but not smooth muscle cells from Apoe−/− mice
as compared to wt mice at 4 weeks, prior to the infiltration of the aorta by inflammatory
cells. Des expression was also elevated in the intimal lesions of 24 week-old Apoe−/− mice
as compared to wt mice (Fig. 6). There were no significant differences in Glb1l expression
in the studies (Fig. 6).
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We have outlined a novel strategy for fine mapping atherosclerosis loci using association on
a sensitized genetic background. In this proof of concept paper, we have provided strong
evidence that the strategy works, with the potential of greatly narrowing the regions of the
mouse genome that contribute to differences in atherosclerosis susceptibility. We have
previously reported the successful application of the EMMA algorithm for correction of the
significant population structure existing among inbred strains of mice, allowing association
analysis using common inbred strains of mice5. As compared to linkage, association analysis
has much improved mapping resolution because it utilizes the many historical
recombinations that have occurred during the generation of inbred strains rather than the
much smaller number of recombinations that occur in a genetic cross.
In order to induce significant atherosclerotic lesions, we utilized a sensitized genetic
background (the human apolipoprotein B transgene). Indeed, the lesions we observed were
about 10-fold larger than those obtained using a high fat, cholic acid diet alone. It is
noteworthy that our results among the BXH subset of RI strains surveyed with the human
apoB transgene were highly concordant with previous studies from the laboratory of Paigen
and coworkers and our laboratory. This suggests that the genetic factors contributing to fatty
streaks and more advanced lesions show considerable overlap. The concordance of our data
with previous genetic studies of atherosclerosis in mice also validates the F1 hybrid strategy
for introducing a sensitizing mutation onto multiple genetic backgrounds. The strategy has
the drawback that it will miss recessive mutations contributing to the trait that are carried by
the partner strain (that is, the strain to which the sensitizing mutation carrying strain is
crossed).
We have used our association strategy to fine map loci that have previously been identified
using linkage, focusing on Ath30. Our original study in BXH.Apoe−/− mice identified the
Ath30 locus on Chr 1 with a 95% confidence interval of 8Mb, from 72 to 80 Mb, containing
over 300 genes25. Using association we are now able to reduce the interval of the Ath30
QTL to a 2 Mb region, between 74.8 to 76.8 Mb on Chr 1, containing only 31 genes. This
allows us to eliminate several positional candidates from our initial cross, such as
2310007B03Rik. Analysis of SNPs with coding changes identified 13 of the 31 genes in the
interval, with missense variants.
Since the locus does not map with plasma lipids, we hypothesized that the gene(s)
underlying the Ath30 locus may be vessel wall specific and thus performed eQTL analysis
of aorta. Two genes had highly significant local eQTL, Des and Glb1l. Des encodes a
proteoglycan that has been previously implicated as a candidate gene for atherosclerosis in
human lesions33 and galactosidase, beta 1-like is an uncharacterized gene.
To further examine the possible role of these candidates in atherogenesis we compared their
expression in cells derived from aortas from wild-type and Apoe−/− mice. These results
indicate that Des mRNA levels are induced prior to initiation of extensive atherosclerosis at
4 weeks of age and elevated expression continues into more advanced lesion development at
24 weeks of age. There were no effects on Glb1l.
The original studies identifying Ath30 indicated that this locus was sex-biased, with
females, but not males, exhibiting a significant QTL.25. The explanation for the failure to
observe sex-bias in the present association study is unclear. However, it is known that the
nature of the sensitizing mutation can affect sex differences (for example,34, 35 and, whereas,
the previous study used an Apoe−/− sensitizing mutation, this study employed a human
APOB transgene. The fact that the sex bias was not observed in our present study could well
be due to differences in sensitizing mutation.
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In conclusion, our results suggest that the mouse may provide another unbiased approach to
identify the genes and pathways contributing to this common forms of atherosclerosis (and
other complex traits), complementing human studies. Analyses in mice may also help
overcome some of the limitations of human studies, particularly the analysis of gene-by-
gene and gene-by-environment interactions.
MATERIALS AND METHODS
Mice and Diets
C57BL/6-tg(APOB) mice were purchased from Taconic and bred with 11 inbred and 11
recombinant inbred strains purchased from the Jackson labs. Progeny of these crosses were
genotyped to verify ApoB100 tg status using forward
(GAATAACTTCCGGAGAGTTGCAAT) and reverse
(CTCTTAGCCCCATTCAGCTCTGAC).
The mice were fed Purina Chow containing 4% fat until 8 weeks of age, and then transferred
to an atherogenic diet, Harland Teklad TD.88031 containing 1.25% cholesterol and 0.3%
cholic acid. After 16 weeks of diet, the mice were fasted for 16 hours, anesthesized with
isoflurane, and blood collected via retro-orbital sinus. Plasmas were stored at −80° C until
assay.
Genotypes for association analysis
A description of the genotypes has been previously described5. We filtered the available
135,000 SNPs to include only those with a minor allele frequency of 10% and less then 10%
missing genotypes. The number of SNPs used was approximately 75,000. A complete list of
genotypes is available at: http://mouse.cs.ucla.edu/mouseHapMap.
Plasma assays
Plasma triglycerides, total cholesterol, unesterified cholesterol, HDL cholesterol, LDL/
VLDL cholesterol, glucose and free fatty acids were measured as previously described36.
Atherosclerotic lesions
The hearts from 288 F1 mice were embedded in OCT and serially sectioned. Every other
section was collected and every third section was stained with oil red O for quantitation of
lesions as previously described36.
BXH.Apoe−/−QTL
A genetic map with markers about 1.5 cM apart was constructed using SNP markers as
described25. Quantitative trait locus (QTL) analysis was performed using R/qtl package37,
using single marker linear regression to model QTL effects. Significant QTL were
determined at a genome-wide p-value of <0.05. The LOD scores corresponding to
significant and suggestive QTL were determined by permuting the data 1000 times38. The
95% confidence interval for QTL was determined using the 1.5 LOD drop.
Aortic Tissue Expression
Flash frozen samples were weighed and homogenized in Qiazol according to the
manufacturer’s protocol. Following homogenization livers were isolated in RNeasy 96
columns (Qiagen) using the manufacturers protocol. RNA integrity was confirmed using the
Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). RNA was processed according to
manufacturer’s specifications and hybridized to Affymetrix Genome HT_MG-430A arrays.
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Detailed methods are included in the Supplemental information. A list of all strains arrayed
is contained in Supplemental Table 6.
Analysis of gene expression in vascular cells of Apoe−/− mice
The cell isolation protocol was adapted from a previously published method for intimal cell
isolation39. After rinsing in cold PBS, the aorta was placed on a glass slide, the surrounding
connective tissue was removed, and the vessel was opened en face. In order to visualize the
endothelial layer, the opened aorta was stained with 30 uL hematoxylin for 3 minutes. The
stain was rinsed off with cold PBS. Collagenase liberase blendzyme 2 (Roche) was diluted
1:100 with PBS, and 25 uL was added to the top of the aorta on the slide and incubated at 37
C for 8 minutes. The slide with collagenase-treated aorta was then placed under a dissecting
microscope, and the endothelial cells were gently pried off using a 26-gauge needle. This
process continued until all endothelial cells were removed, determined by the lack of
hematoxylin-dyed nuclei on the surface of the sample. The liquid containing the endothelial
cells was then pipetted with a thin pipet tip into RNA extraction buffer. RNA was extracted
using the RNAqueous®-Micro Kit by Ambion following the manufacturer’s protocol.
Aortas with the intimal layer removed, as described above, consisted primarily of smooth
muscle cells. These were homogenized in Qiazol for 30 seconds, and RNA was isolated with
the Qiagen RNeasy kit standard protocol. Transcript levels were quantitated by PCR
(RocheLightCycler 480). cDNA was synthesized using the manufacturers recommendation
(Applied Biosystems). Primer sequences are shown in Supplemental Table VI.
Statistical analysis
All statistical analyses for the project were performed using the R language and environment
for statistical computing (http://cran.r-project.org/). We calculated the FDR threshold of
EMMA corrected based on mapping results from males and female datasets using the
package q-value. The binomial probability was calculated using the function, binom.test.
Using the assumption that each locus was 20 Mb we estimated that 22% of the mouse
genome contained a atherosclerosis QTL. A similar estimate for HDL QTL has been
previously reported20. We applied the previously described EMMA linear mixed model to
account for the population structure and genetic relatedness among strains in the genome-
wide association mapping5, 19. A description of EMMA is provided in the supplemental
information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Atherosclerosis and lipoprotein levels vary among inbred strains with hApoB100 Tg
Three to ten mice of each strain per sex were examined for the given phenotypes as
described in the Methods. Panels (A) and (B) show female and male aortic sinus
atherosclerosis lesion sizes, respectively. Strains are listed on the X-axis and average lesion
sizes in um2 are shown on the Y-axis. Panels (C) and (D) show high-density lipoprotein
(HDL) levels, in males and females, respectively. Strains are listed on the X-axis and
average HDL (mg/dl) on the Y-axis. Panels (E) and (F) show correlations of plasma HDL
levels and atherosclerosis in female and male mice, respectively. Pearson r2- values and
corresponding p-values are shown in upper right of graph. Values are mean ± SEM.
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Figure 2. High resolution genetic mapping of atherosclerosis susceptibility
Loci detected for aortic sinus lesion size are shown for female mice (A), male mice (B), and
combined sexes using sex as a covariate (C). X-axis is genomic position and Y-axis is
−log10 of the p-value following correction for population structure, as described in Methods.
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Figure 3. Replication of association results in historical data
The study Paigen 1 was downloaded from the mouse genome informatics website. Wild-
derived strains were removed and remaining data was mapped using EMMA. Data for the
Ath30 (A) and Ath8 (B) loci are presented for female mice. Red circles indicate peak SNPs
in the current study.
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Figure 4. High resolution mapping of Ath30 locus
(A) Genetic association results between 74 and 78 Mb on Chr 1 are shown. Mapping data is
for both genders using sex as a covariate. (B) Physical locations of genes are denoted by
green horizontal bars (reverse strand) and purple horizontal bars (forward strand). (C) The
lower panel shows a heatmap of the correlations of SNPs at Ath30 locus. Red indicates
SNPs that are highly correlated (in strong linkage disequilibrium (LD) with each other) and
defines the critical region for candidate gene selection.
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Figure 5. Aortic eQTL analysis identifies candidate genes
Using aortic tissue from non-hyperlipidemic mice, mRNA levels were quantitated in 93
strains using Affymetrix 430A microarrays. These data were analyzed using EMMA to
identify genes within the Ath30 locus whose expression is under significant local genetic
regulation. Two genes, Des (A) and Glb1l (B) were found to have significant local
expression QTL.
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Figure 6. Aortic and intimal expression of candidate genes during atherogenesis
Intimal and smooth muscle cells were isolated as described in the methods. Expression of
Glb1l and Des were quantitated in endothelial and intimal cells (A and B) or aortic smooth
muscle cells (C and D) by qPCR. Expression values are normalized to B2m and significant
differences determined by t-test. Values are mean ± SEM. ** indicates significant
differences (p<0.01).
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